CLINICS 2010;65(12):1351-1356
=============================

Replace: [Table 1](#t1-cln_66p365){ref-type="table"}

For:[](#t1-cln_66p365){ref-type="table"}

CLINICS 2010;65(12):1399-1400
=============================

Replace: RejaneMattar, Maria Monteiro para Maria do Socorro Monteiro, Joyce Matie Silva para Joyce Matie Kinoshita da Silva, FlairCarrilhopara Flair José Carrilho

For: Rejane Mattar, Maria do Socorro Monteiro, Joyce Matie Kinoshita da Silva, Flair José Carrilho

  Group              η    Infused substance   Infusion period                    Posology
  ------------------ ---- ------------------- ---------------------------------- ------------------------
  A1 (control)       10   SS 0.9%             Between the 5^th^ and 40^th^ POD   Twice a week
  A2 (prophylaxis)   10   SCFA                Between the 5^th^ and 40^th^ POD   Twice a week
  B1 (control)       10   SS 0.9%             After the 40^th^ POD               Twice a day for 7 days
  B2 (treatment)     10   SCFA                After the 40^th^ POD               Twice a day for 7 days

SS  =  saline solution. SCAF =  short-chain fatty acids. POD  =  post-operatory day.
